Short-term and long-term safety of glucocorticoids in rheumatoid arthritis

Academic Article


  • Despite over 60 years of use, glucocorticoids continue to be a controversial therapy in rheumatoid arthritis (RA). This stems largely from their measured a well as their perceived toxicity. However, a paucity of top tier evidence from clinical trials or very carefully controlled observational studies leads to limited evidence supporting potential causal relations between low-dose glucocorticoids and adverse outcomes. Several new studies have contributed to an improved un- derstanding of these associations and they are reviewed here along with highlights from the older body of literature examining these important outcomes.
  • Authors

    Author List

  • Saag KG
  • Volume

  • 70
  • Issue

  • SUPPL. 1